
Remodeling and increasing body volumes represent a significant demand in surgery and aesthetic medicine.
The laboratories have created a specific product for the body, Macrolane which has been replaced by HYACORP. Macrolane and HYACORP.
Macrolane is a hyaluronic acid, of non-animal origin (NASHA Technology) for the body. In 2017 the Galderma laboratory stopped its commercialization in France because it would have been used in forbidden indications, like the breasts or the penis (many cases of not resorbable cysts were carried over). Macrolane has been replaced by HYACORPS from the German laboratory Bioscience, this product has a CE mark and is used in the same indications as Macrolane.
INDICATIONS

In France breast augmentation with hyaluronic acid is prohibited. It is used for buttock augmentation, calf augmentation (to learn more click on each word to access the page) and correction of post liposuction concavities.
SESSION
A prior consultation is usually done. Aspirin, antinflammatories and anticoagulants will be stopped one week before the session. The injection is done after having performed a local anesthesia, possibly Kalinox anesthesia is performed. The product is placed under the skin using cannulas (needles whose tip is rounded). The patient returns home after the session.

Side effects and after effects
The procedure does not cause downtime but the resumption of sport activities can be done only one week after the injection. Do not squeeze or exert pressure on the injected area for one week.The patient is reviewed one month after the procedure for possible retouching. The result lasts about 18 months, every year it will be necessary to inject the 60% of the product initially used if one wants a stable result.
Contraindications
Les contre-indications sont les suivantes :
-Grossesse, allaitement.
-Prise d’anticoagulants.
-Certaines conditions cliniques, diabète, insuffisance cardiaque ou rénale sévère…
-Maladie auto-immune.
BEFORE AND AFTER PICTURES




Testimonials-reviews
G. MARSH
H. MILLER
L. MONTGOMERY
M. BURNETT